Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Nov 1;11(1):21385.
doi: 10.1038/s41598-021-00827-0.

A semi-automated, isolation-free, high-throughput SARS-CoV-2 reverse transcriptase (RT) loop-mediated isothermal amplification (LAMP) test

Affiliations
Comparative Study

A semi-automated, isolation-free, high-throughput SARS-CoV-2 reverse transcriptase (RT) loop-mediated isothermal amplification (LAMP) test

Jonas Schmidt et al. Sci Rep. .

Abstract

Shortages of reverse transcriptase (RT)-polymerase chain reaction (PCR) reagents and related equipment during the COVID-19 pandemic have demonstrated the need for alternative, high-throughput methods for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-mass screening in clinical diagnostic laboratories. A robust, SARS-CoV-2 RT-loop-mediated isothermal amplification (RT-LAMP) assay with high-throughput and short turnaround times in a clinical laboratory setting was established and compared to two conventional RT-PCR protocols using 323 samples of individuals with suspected SARS-CoV-2 infection. Limit of detection (LoD) and reproducibility of the isolation-free SARS-CoV-2 RT-LAMP test were determined. An almost perfect agreement (Cohen's kappa > 0.8) between the novel test and two classical RT-PCR protocols with no systematic difference (McNemar's test, P > 0.05) was observed. Sensitivity and specificity were in the range of 89.5 to 100% and 96.2 to 100% dependent on the reaction condition and the RT-PCR method used as reference. The isolation-free RT-LAMP assay showed high reproducibility (Tt intra-run coefficient of variation [CV] = 0.4%, Tt inter-run CV = 2.1%) with a LoD of 95 SARS-CoV-2 genome copies per reaction. The established SARS-CoV-2 RT-LAMP assay is a flexible and efficient alternative to conventional RT-PCR protocols, suitable for SARS-CoV-2 mass screening using existing laboratory infrastructure in clinical diagnostic laboratories.

PubMed Disclaimer

Conflict of interest statement

DR holds an executive position and is a shareholder in Medipan and GA Generic Assays, which are diagnostic manufacturers. FB is the managing director of the Institute for Laboratory Medicine. JS, SB and HH are employees of this institution. The remaining authors declare no potential conflict of interest.

Figures

Figure 1
Figure 1
Amplification curves of SARS-CoV-2 RT-LAMP runs using an intercalating fluorescent dye for detection. During the 30 min isothermal incubation (65 °C), the fluorescence signal is read minutely on the FAM channel. A threshold is applied to identify positive samples and calculate the threshold time (Tt) value.
Figure 2
Figure 2
Comparison of the SARS-CoV-2 RT-LAMP Tt values and the RT-PCR Ct values. The dashed lines represent the negative cut-offs. Artificial Ct and Tt values above these cut-offs were assigned to negative samples for data visualization purpose. Spearman correlation results are shown. Only true positive samples were included into the correlation analysis. (A) SARS-CoV-2 RT-LAMP with RNA isolation compared to the in-house RT-PCR. (B) SARS-CoV-2 RT-LAMP with RNA isolation compared to the LabsystemsDx RT-PCR (E gene target). (C) SARS-CoV-2 RT-LAMP with RNA isolation compared to the LabsystemsDx RT-PCR (N gene target). (D) SARS-CoV-2 RT-LAMP with RNA isolation compared to the LabsystemsDx RT-PCR (ORF1ab gene target). (E) SARS-CoV-2 RT-LAMP without RNA isolation compared to the in-house RT-PCR.

Similar articles

Cited by

References

    1. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7. - DOI - PMC - PubMed
    1. Younes N, et al. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020;12:582. doi: 10.3390/v12060582. - DOI - PMC - PubMed
    1. Mathuria JP, Yadav R. Laboratory diagnosis of SARS-CoV-2—A review of current methods. J. Infect. Public Health. 2020;13:901–905. doi: 10.1016/j.jiph.2020.06.005. - DOI - PMC - PubMed
    1. V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19:155–170. doi: 10.1038/s41579-020-00468-6. - DOI - PMC - PubMed
    1. Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41:1100–1115. doi: 10.1016/j.it.2020.10.004. - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts